Oncology Institute, Inc. (TOI)

Oncology Institute, Inc.
TickerTOIBörseNasdaq
ISINUS68236X1000CIK0001799191
5,31
Schluss · 12.06.2026
1T+3,5 %1W+9,0 %1M+30,1 %3M+87,0 %6M+40,5 %1J+100,4 %
GCS 59 → +0,0
TSI 32,1 · 33,9 ▼ 03.06.
8-K 5.02 23.02.26· 111T
Insider ▼ 08.06.26· 6T
PDF

Glück Conviction Score™

TOI Oncology Institute, Inc.
Eingeschränkte Aussagekraft — erst 66 % der Signal-Gewichte sind mit Daten unterlegt.
Conviction Score
59
Neutral
Effektiv: Neutral Niedrig
Bedeutung der Einstufung ⓘ
Insider
28,4
1 Insider, 1,4M $ Volumen
Institutionell
54,5
21 neu, 50 erhöht, -15724K $ netto
Aktivist
14,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

80
Technical-Score: 80 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 66.7 % — 8 bullisch / 3 bärisch / 1 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %3.99+33.0 % vs SMA50
Kurs vs SMA200Bullisch15 %3.53+50.3 % vs SMA200
SMA-CrossBullisch10 %GOLDENvor 16 Tagen @ 4.20
EMA20 vs EMA50Bullisch5 %4.65EMA50: 4.15
MACD-HistogrammBullisch10 %0.028Bullisch
RSI(14)Neutral10 %67.8Neutral (30–70)
Stoch %K(14)Bärisch5 %80.1Überkauft
ADX(14)+DIBullisch10 %42.5+DI: 31.0 / −DI: 15.4
Z-Score(60)Bärisch5 %2.24Extrem überkauft
52W-PositionBullisch5 %100.0 %Hoch 5.31 / Tief 2.05
Bollinger(20,2σ)Bärisch5 %98.3 %Upper 5.33 / Mid 4.62 / Lower 3.90
LinReg-Slope(60)Bullisch10 %+0.0354R²=0.88 / annualisiert +231.8 %

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-06-08Podnos YaleOfficer, Chief Medical OfficerOpen Market Sale-23.4515,38-126.093,68-12,2%
2026-06-04Chernett Jorey10% OwnerOpen Market Purchase12.0004,7557.000,00+5,5%
2026-05-20Chernett Jorey10% OwnerOpen Market Purchase33.5004,07136.345,00+13,2%
2026-05-19Chernett Jorey10% OwnerOpen Market Purchase5.0004,0520.250,00+2,0%
2026-05-19Chernett Jorey10% OwnerOpen Market Purchase30.0004,09122.700,00+11,8%
2026-04-16Kaushal MohitDirectorOpen Market Sale-38.4333,50-134.534,72-13,0%
2026-04-14Kaushal MohitDirectorOpen Market Sale-57.2863,50-200.598,39-19,4%
2026-04-09Chernett Jorey10% OwnerOpen Market Purchase20.0003,1062.000,00+6,0%
2026-03-27Chernett Jorey10% OwnerOpen Market Purchase27.4292,9681.189,84+7,8%
2026-03-26Chernett Jorey10% OwnerOpen Market Purchase50.0003,15157.500,00+15,2%
2026-03-24Chernett Jorey10% OwnerOpen Market Purchase125.0003,11388.750,00+37,5%
2026-03-20Chernett Jorey10% OwnerOpen Market Purchase25.0003,3583.750,00+8,1%
2026-03-17Chernett Jorey10% OwnerOpen Market Purchase75.0003,42256.500,00+24,8%
2026-03-16Chernett Jorey10% OwnerOpen Market Purchase60.9853,29200.640,65+19,4%
2026-03-13Chernett Jorey10% OwnerOpen Market Purchase263.0002,92767.960,00+74,1%
2026-01-02Carter Robert RossOfficer, Chief Financial OfficerOpen Market Sale-2473,56-879,32-0,1%
2025-12-15Hively BradDirectorOpen Market Sale-13.3333,77-50.290,74-4,9%
2025-11-18Pacala Mark LDirectorOpen Market Sale-2.1604,00-8.640,00-0,8%
2025-11-18Pacala Mark LDirectorOpen Market Sale-46.6304,00-186.520,00-18,0%
2025-11-18Pacala Mark LDirectorOpen Market Sale-1.2104,00-4.840,00-0,5%
2025-09-04M33 Growth I L.P.Director, 10% OwnerOpen Market Sale-681.8323,09-2.106.860,88-203,3%
2025-09-04M33 Growth I L.P.Director, 10% OwnerOpen Market Sale-6.018.1683,09-18.596.139,12-1794,7%
2025-08-19Hively BradDirectorOpen Market Sale-20.2214,06-82.097,26-7,9%

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
VANGUARD GROUP INC4.748.63504.748.63516.905.141Neu+100,0%
BlackRock, Inc.4.415.8673.905.333510.53413.556.712Aufgestockt+13,1%
VANGUARD CAPITAL MANAGEMENT LLC3.476.78103.476.78110.673.718Neu+100,0%
DEERFIELD MANAGEMENT COMPANY, L.P.3.360.0523.360.052010.315.360Unverändert0,0%
Kanen Wealth Management LLC2.777.8582.976.144-198.2868.528.024Reduziert-6,7%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.464.3592.459.8094.5507.565.582Aufgestockt+0,2%
CITADEL ADVISORS LLC2.354.667477.1001.877.5677.228.828Aufgestockt+393,5%
BALYASNY ASSET MANAGEMENT L.P.1.826.3704.781.537-2.955.1675.606.956Reduziert-61,8%
GEODE CAPITAL MANAGEMENT, LLC1.757.8471.570.454187.3935.397.829Aufgestockt+11,9%
WEXFORD CAPITAL LP1.711.3231.533.456177.8675.253.762Aufgestockt+11,6%
CenterBook Partners LP1.568.4233.029.312-1.460.8894.815.059Reduziert-48,2%
STATE STREET CORP1.461.4541.351.624109.8304.486.664Aufgestockt+8,1%
GOLDMAN SACHS GROUP INC1.351.899570.424781.4754.150.330Aufgestockt+137,0%
BRC Group Holdings, Inc.929.734663.376266.3582.854.283Aufgestockt+40,2%
RENAISSANCE TECHNOLOGIES LLC902.809721.900180.9092.771.624Aufgestockt+25,1%
SUSQUEHANNA INTERNATIONAL GROUP, LLP726.669962.550-235.8812.230.874Reduziert-24,5%
JANE STREET GROUP, LLC628.8941.142.415-513.5211.930.704Reduziert-45,0%
Ensign Peak Advisors, Inc626.8520626.8521.924.436Neu+100,0%
UBS Group AG574.652287.686286.9661.764.182Aufgestockt+99,7%
NORTHERN TRUST CORP558.455499.24459.2111.714.457Aufgestockt+11,9%
FourWorld Capital Management LLC499.1960499.1961.532.532Neu+100,0%
Massar Capital Management, LP400.0000400.0001.424.000Neu+100,0%
Dauntless Investment Group, LLC462.0570462.0571.418.515Neu+100,0%
JPMORGAN CHASE & CO386.7780386.7781.376.930Neu+100,0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP419.423155.724263.6991.287.629Aufgestockt+169,3%
GatePass Capital, LLC360.0000360.0001.281.600Neu+100,0%
FreeGulliver LLC355.6720355.6721.266.192Neu+100,0%
MARSHALL WACE, LLP342.265180.300161.9651.050.753Aufgestockt+89,8%
TWO SIGMA INVESTMENTS, LP307.754262.05045.704944.805Aufgestockt+17,4%
Maven Securities LTD251.1280251.128894.016Neu+100,0%
Mount Lucas Management LP250.000250.0000767.500Unverändert0,0%
Centiva Capital, LP224.2450224.245688.432Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC214.915208.2656.650659.789Aufgestockt+3,2%
Informed Momentum Co LLC182.5090182.509649.732Neu+100,0%
TIFF ADVISORY SERVICES, LLC195.469195.569-100564.905Reduziert-0,1%
MORGAN STANLEY171.940222.053-50.113527.855Reduziert-22,6%
BOOTHBAY FUND MANAGEMENT, LLC137.79285.23052.562423.021Aufgestockt+61,7%
ExodusPoint Capital Management, LP117.3260117.326417.681Neu+100,0%
MILLENNIUM MANAGEMENT LLC131.522193.141-61.619403.773Reduziert-31,9%
SEI INVESTMENTS CO111.5530111.553397.129Neu+100,0%
Cetera Investment Advisers128.19524.287103.908393.559Aufgestockt+427,8%
Jump Financial, LLC116.43025.27991.151357.440Aufgestockt+360,6%
T3 Companies, LLC111.900201.100-89.200343.533Reduziert-44,4%
State of Wyoming103.617106.673-3.056318.104Reduziert-2,9%
KINGSWOOD WEALTH ADVISORS, LLC103.20098.7004.500316.824Aufgestockt+4,6%
Nuveen, LLC95.26476.67218.592292.460Aufgestockt+24,2%
Private Advisor Group, LLC94.17062.22231.948289.104Aufgestockt+51,3%
XTX Topco Ltd90.34646.52243.824277.362Aufgestockt+94,2%
HighTower Advisors, LLC83.91985.851-1.932257.631Reduziert-2,3%
Lee Financial Co81.36281.3620249.782Unverändert0,0%

Top-Fondshalter (Stand: 31.03.2026)

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
BlackRock, Inc.4.415.8673.905.333+13,1%13.556.71211,14
VANGUARD CAPITAL MANAGEMENT LLC3.476.7810+100,0%10.673.7188,77
DEERFIELD MANAGEMENT COMPANY, L.P.3.360.0523.360.0520,0%10.315.3608,47
Kanen Wealth Management LLC2.777.8582.976.144-6,7%8.528.0247,01
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.464.3592.459.809+0,2%7.565.5826,22
CITADEL ADVISORS LLC2.354.667477.100+393,5%7.228.8285,94
BALYASNY ASSET MANAGEMENT L.P.1.826.3704.781.537-61,8%5.606.9564,61
GEODE CAPITAL MANAGEMENT, LLC1.757.8471.570.454+11,9%5.397.8294,43
WEXFORD CAPITAL LP1.711.3231.533.456+11,6%5.253.7624,32
CenterBook Partners LP1.568.4233.029.312-48,2%4.815.0593,96
STATE STREET CORP1.461.4541.351.624+8,1%4.486.6643,69
GOLDMAN SACHS GROUP INC1.351.899570.424+137,0%4.150.3303,41
BRC Group Holdings, Inc.929.734663.376+40,2%2.854.2832,34
RENAISSANCE TECHNOLOGIES LLC902.809721.900+25,1%2.771.6242,28
SUSQUEHANNA INTERNATIONAL GROUP, LLP726.669962.550-24,5%2.230.8741,83
JANE STREET GROUP, LLC628.8941.142.415-45,0%1.930.7041,59
Ensign Peak Advisors, Inc626.8520+100,0%1.924.4361,58
UBS Group AG574.652287.686+99,7%1.764.1821,45
NORTHERN TRUST CORP558.455499.244+11,9%1.714.4571,41
FourWorld Capital Management LLC499.1960+100,0%1.532.5321,26

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.202611344,6137
31.12.202511742,9142
30.09.202510935,2122
30.06.20257732,767
31.03.20254217,220
31.12.20243014,65

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
GatePass Capital, LLC360.0001.281.600
T3 Companies, LLC201.100715.916
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP155.724554.377
SEI INVESTMENTS CO111.553397.129
Creative Planning78.633279.933
Point72 Asset Management, L.P.69.275246.619
GROUP ONE TRADING LLC62.140221.218
Caption Management, LLC50.100178.356
XTX Topco Ltd46.522165.618
nVerses Capital, LLC31.595112.478

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
BALYASNY ASSET MANAGEMENT L.P.4.781.5372.263.200+89.9 %17.022.272
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.459.8092.255.559+1104.3 %8.756.920
Kanen Wealth Management LLC2.976.1441.134.043+61.6 %10.712
JANE STREET GROUP, LLC1.142.415885.627+344.9 %4.066.998
SUSQUEHANNA INTERNATIONAL GROUP, LLP962.550770.850+402.1 %3.426.678
BlackRock, Inc.3.905.333470.458+13.7 %13.902.986
CITADEL ADVISORS LLC477.100367.339+334.7 %1.698.476
JPMORGAN CHASE & CO386.778362.349+1483.3 %1.376.930
CenterBook Partners LP3.029.312324.662+12.0 %10.784.351
STATE STREET CORP1.351.624221.599+19.6 %4.811.781

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
UBS Group AG287.686-768.176-72.8 %1.024.162
MILLENNIUM MANAGEMENT LLC193.141-757.860-79.7 %687.582
TIFF ADVISORY SERVICES, LLC195.569-661.059-77.2 %696.226
BOOTHBAY FUND MANAGEMENT, LLC85.230-162.654-65.6 %303.419
BRC Group Holdings, Inc.663.376-148.170-18.3 %2.361.619
GOLDMAN SACHS GROUP INC570.424-111.219-16.3 %2.030.709
Squarepoint Ops LLC61.764-80.790-56.7 %219.880
NATIONAL BANK OF CANADA /FI/17.733-73.708-80.6 %62.951
Jump Financial, LLC25.279-58.121-69.7 %89.993
DEUTSCHE BANK AG\47.848-40.633-45.9 %170.339

Aktivisten & Großaktionäre (13D/13G)

DatumInvestorTypAnteilAktienΔZweck
15.05.2026M33 Growth I GP LLCAktivist (13D/A)4,94 %5.002.656-0,52 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
15.05.2026TOI M, LLCAktivist (13D/A)Ausstieg00,00 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
15.05.2026M33 Growth I L.P.Aktivist (13D/A)4,94 %5.002.656NeuItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
16.03.2026Chernett JoreyPassiv (13G/A)10,20 %10.115.944+5,00 pp
15.01.2026Chernett JoreyPassiv (13G)5,20 %5.114.944Neu
20.11.2025M33 Growth I GP LLCAktivist (13D/A)5,46 %6.802.656-4,33 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
20.11.2025TOI M, LLCAktivist (13D/A)Ausstieg0-0,63 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
20.11.2025M33 Growth I LPAktivist (13D/A)5,46 %6.802.656-4,33 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this Sc…
05.09.2025TOI M, LLCAktivist (13D/A)0,63 %590.892-1,14 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this St…
05.09.2025M33 Growth I LPAktivist (13D/A)9,79 %9.290.838-10,20 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this St…
05.09.2025M33 Growth I GP LLCAktivist (13D/A)9,79 %9.290.838-10,20 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this St…
24.06.2025FOG Ventures Investments, LLCPassiv (13G/A)Ausstieg0-6,20 pp
24.06.2025Daniel MurilloPassiv (13G/A)Ausstieg0-6,20 pp
23.04.2025OncologyCare Partners, LLCAktivist (13D/A)4,70 %4.109.771-0,80 ppItem 4 is hereby supplemented as follows: On August 31, 2023, Mr. Sarin resigned, effec…
23.04.2025Ravi SarinAktivist (13D/A)4,70 %4.109.771-0,80 ppItem 4 is hereby supplemented as follows: On August 31, 2023, Mr. Sarin resigned, effec…
28.03.2025TOI M, LLCAktivist (13D/A)1,77 %1.552.580-0,33 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this S…
28.03.2025M33 Growth I LPAktivist (13D/A)19,99 %17.543.172+1,39 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this S…
28.03.2025M33 Growth I GP LLCAktivist (13D/A)19,99 %17.543.172+1,39 ppItem 4 is hereby supplemented as follows: The information set forth in Item 3 of this S…
06.12.2024Abigail P. JohnsonPassiv (13G/A)Ausstieg0Neu
06.12.2024FMR LLCPassiv (13G/A)Ausstieg0Neu
20.08.2024 Havencrest Healthcare Partners GP, LLCAktivist (13D/A)0,33 %1Neu
20.08.2024 TOI HC I, LLCAktivist (13D/A)0,13 %1Neu
20.08.2024 Havencrest Healthcare Partners, L.P.Aktivist (13D/A)0,13 %1Neu
02.01.2024TOI HC I, LLCAktivist (13D/A)11,93 %1-6,97 pp
02.01.2024Havencrest Healthcare Partners GP, LLCAktivist (13D/A)12,04 %1-6,86 pp
02.01.2024Havencrest Healthcare Partners, L.P.Aktivist (13D/A)11,93 %1-6,97 pp
03.04.2023Jimmy Holdings, Inc.Passiv (13G/A)4,40 %3.312.216-0,90 pp
03.04.2023Richy AgajanianPassiv (13G/A)4,80 %3.565.652-0,90 pp
10.01.2023Jimmy Holdings, Inc.Passiv (13G/A)5,30 %3.866.433-4,90 pp
10.01.2023Richy AgajanianPassiv (13G/A)5,70 %4.119.869-5,23 pp
07.11.2022TOI HC I, LLCAktivist (13D/A)18,90 %1-1,10 pp
07.11.2022Havencrest Healthcare Partners GP, LLCAktivist (13D/A)18,90 %1-1,10 pp
07.11.2022Havencrest Healthcare Partners, L.P.Aktivist (13D/A)18,90 %1-1,10 pp
26.09.2022TOI M, LLCAktivist (13D/A)2,10 %1.552.5800,00 pp
26.09.2022M33 Growth I GP LLCAktivist (13D/A)18,60 %13.703.803+0,50 pp
26.09.2022M33 Growth I LPAktivist (13D/A)18,60 %13.703.803+0,50 pp
21.09.2022TOI HC I, LLCAktivist (13D/A)20,00 %1-1,00 pp
21.09.2022Havencrest Healthcare Partners GP, LLCAktivist (13D/A)20,00 %1-1,00 pp
21.09.2022Havencrest Healthcare Partners, L.P.Aktivist (13D/A)20,00 %1-1,00 pp
12.07.2022TOI M, LLCAktivist (13D/A)2,10 %1.552.580Neu

Stammdaten

The Oncology Institute, Inc., ein Onkologie-Unternehmen, erbringt medizinische Onkologie-Dienstleistungen in den Vereinigten Staaten. Seine Dienstleistungen umfassen Arztdienstleistungen, interne Infusions- und Apothekendienste, klinische Versuchsdienste, Strahlentherapie, ambulante Stammzelltransplantations- und Transfusionsprogramme sowie Patientenunterstützung. Das Unternehmen bietet und verwaltet auch klinische Versuchsdienste wie die Verwaltung klinischer Versuche, Palliativcare-Programme und Stammzelltransplantationsdienste. Es bedient erwachsene und ältere Krebspatienten. Das Unternehmen betreibt 67 Klinikstandorte. The Oncology Institute, Inc. wurde 2007 gegründet und hat seinen Sitz in Cerritos, Kalifornien.

Unternehmen & Branche

NameOncology Institute, Inc.
TickerTOI
CIK0001799191
BoerseNasdaq
SektorHealthcare
IndustrieMedical - Care Facilities
SIC8011 · Services-Offices & Clinics of Doctors of Medicine

Wertpapier & Kennzahlen

CUSIP68236X100
ISINUS68236X1000
TypCommon Stock
Marktkapitalisierung507,2 Mio. USD
Beta0,31

Bewertung

KUV (P/S)1,01 vs. 3,52 (2021)
FCF-Rendite-5,5 % vs. -5,0 % (2021)

Qualität & Bilanz

Operative Marge-7,2 % vs. -22,6 % (2021)
Nettomarge-12,1 % vs. -5,4 % (2021)
ROIC-68,8 % vs. -10,5 % (2021)
Zinsdeckungsgrad-3,2 vs. -143,3 (2021)

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025Verlauf
Bewertung
KBV (P/B)6,860,982,656,52
KUV (P/S)3,520,480,470,060,70
FCF-Rendite-5,0 %-55,7 %-27,0 %-129,6 %-7,9 %
Buyback-Rendite0,0 %7,4 %0,7 %0,0 %
Qualität & Bilanz
Operative Marge-22,6 %-32,5 %-23,8 %-15,3 %-7,2 %
Nettomarge-5,4 %0,1 %-25,6 %-16,4 %-12,1 %
ROIC-10,5 %0,1 %-47,0 %-51,0 %-68,8 %
Zinsdeckungsgrad-143,3-11,4-8,0-3,2

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q147.441.000-2.492.000-0,02168.230.000-16.285.000
2025-12-3110-K502.729.000-60.606.000-0,54164.656.000-15.720.000
2025-09-3010-Q136.564.000-16.504.000-0,14163.619.000-12.274.000
2025-06-3010-Q119.802.000-17.009.000-0,15159.798.000-8.985.000
2025-03-3110-Q104.406.000-19.585.000-0,21164.002.0005.069.000
2024-12-3110-K393.412.000-64.663.000-0,71172.717.0003.589.000
2024-09-3010-Q99.901.000-16.113.000-0,18179.183.00015.482.000
2024-06-3010-Q98.578.000-15.479.000-0,17179.602.00029.206.000
2024-03-3110-Q94.666.000-19.889.000-0,22204.532.00041.296.000
2023-12-3110-K324.239.000-83.068.000-0,92209.240.00057.025.000
2023-09-3010-Q82.035.000-17.419.000-0,19218.353.00071.849.000
2023-06-3010-Q80.224.000-16.897.000-0,19229.959.00084.722.000
2023-03-3110-Q76.192.000-29.998.000-0,33234.633.00098.406.000
2022-12-3110-K252.483.000152.000-0,21261.665.000123.175.000
2022-09-3010-Q64.977.000-2.674.000-0,17283.802.000127.934.000
2022-06-3010-Q60.921.000-5.453.000-0,06189.740.000123.983.000
2022-03-3110-Q55.161.00019.286.0000,21206.512.000131.998.000
2021-12-3110-K203.003.000-10.927.000-0,16203.439.000104.159.000
2021-09-3010-Q52.275.000-2.980.000-0,05230.299.73347.533.000
2021-09-3010-Q/A-432.034230.299.733-24.902.585

Umsatz nach Segmenten & Regionen

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Health Care Specialty Pharmacy269,2 Mio.36,8 %Neu
Health Care Patient Service229,0 Mio.204,9 Mio.213,5 Mio.166,8 Mio.124,1 Mio.31,3 %+11,8%
Fee For Service148,5 Mio.136,2 Mio.143,1 Mio.105,4 Mio.69,8 Mio.20,3 %+9,0%
Capitated Revenue80,5 Mio.68,7 Mio.70,4 Mio.61,3 Mio.54,3 Mio.11,0 %+17,2%
Clinical Research Trials And Other Revenue4,6 Mio.8,6 Mio.6,9 Mio.6,4 Mio.6,4 Mio.0,6 %-47,0%
Dispensary Revenue179,9 Mio.103,8 Mio.79,3 Mio.72,6 Mio.

Quartalsergebnisse (Earnings)

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202607.05.2026147,4 Mio. USD-0,02
Q3 202530.09.202513.11.2025136,6 Mio. USD-0,14
Q2 202530.06.202513.11.2025119,8 Mio. USD-0,15
Q1 202531.03.202507.05.2026104,4 Mio. USD-0,21
Q3 202430.09.202413.11.202599,9 Mio. USD-0,18
Q2 202430.06.202413.11.202598,6 Mio. USD-0,17
Q1 202431.03.202413.11.202594,7 Mio. USD-0,22
Q3 202330.09.202313.11.202482,0 Mio. USD-0,19
Q2 202330.06.202313.11.202480,2 Mio. USD-0,19

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
07.05.2026 10-Q 31.03.2026 37 Tage SEC »
12.03.2026 10-K 31.12.2025 71 Tage SEC »
13.11.2025 10-Q 30.09.2025 44 Tage SEC »
13.08.2025 10-Q 30.06.2025 44 Tage SEC »
14.05.2025 10-Q 31.03.2025 44 Tage SEC »
26.03.2025 10-K 31.12.2024 85 Tage SEC »
13.11.2024 10-Q 30.09.2024 44 Tage SEC »
13.08.2024 10-Q 30.06.2024 44 Tage SEC »
22.05.2024 10-K/A 31.12.2023 143 Tage SEC »
22.05.2024 10-Q/A 31.03.2024 52 Tage SEC »
14.05.2024 10-Q 31.03.2024 44 Tage SEC »
22.04.2024 10-K/A 31.12.2023 113 Tage SEC »
28.03.2024 10-K 31.12.2023 88 Tage SEC »
08.11.2023 10-Q 30.09.2023 39 Tage SEC »
09.08.2023 10-Q 30.06.2023 40 Tage SEC »
10.05.2023 10-Q 31.03.2023 40 Tage SEC »
16.03.2023 10-K 31.12.2022 75 Tage SEC »
09.11.2022 10-Q 30.09.2022 40 Tage SEC »
09.08.2022 10-Q 30.06.2022 40 Tage SEC »
10.05.2022 10-Q 31.03.2022 40 Tage SEC »
11.03.2022 10-K 31.12.2021 70 Tage SEC »
14.12.2021 10-K/A 31.12.2020 348 Tage SEC »
14.12.2021 10-Q/A 30.09.2021 75 Tage SEC »
08.11.2021 10-Q 30.09.2021 39 Tage SEC »
16.08.2021 10-Q 30.06.2021 47 Tage SEC »
28.05.2021 10-Q 31.03.2021 58 Tage SEC »
24.05.2021 10-K/A 31.12.2020 144 Tage SEC »
30.03.2021 10-K 31.12.2020 89 Tage SEC »
13.11.2020 10-Q 30.09.2020 44 Tage SEC »
13.08.2020 10-Q 30.06.2020 44 Tage SEC »

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
23.02.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECAct. ☐.       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain…
07.05.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECe Exchange Act. ☐.     Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of…
23.09.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
06.09.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
01.09.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
22.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECto Section 13(a) of the Exchange Act. Item 5.02.     Departure of Directors or Certain Officers; Election of Directors…
01.12.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
22.09.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
05.05.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
04.04.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
07.03.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
09.12.2021Item 4.02 — BilanzkorrekturenEXTREMSECItem 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim…
18.11.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
18.05.2021Item 4.02 — BilanzkorrekturenEXTREMSECItem 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review…
13.03.2020Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-05-115194,002.076
2026-05-041.9964,058.084
2026-04-2117.1063,5260.213
2026-04-2015.6233,5455.305
2026-04-177.6193,5426.971
2026-04-161.5653,435.368
2026-04-1520.4183,3869.013
2026-04-1331.5333,0897.122
2026-04-1018.5913,1157.818
2026-04-0988.1243,10273.184
2026-04-063.8383,1211.975
2026-04-021.2773,144.010
2026-03-31512,83144
2026-03-278.1123,1025.147
2026-03-2623,126
2026-03-251.0673,133.340
2026-03-232803,32930
2026-03-1916.8633,6060.707
2026-03-1826.9973,5996.919
2026-03-1369.5492,62182.218
2026-03-1062,7316
2026-03-0997.5252,78271.120
2026-03-0610.2102,8529.099
2026-03-0217.3822,8950.234
2026-02-2642,8611
2026-02-2542,5810
2026-02-248.0172,5520.443
2026-02-2329.3462,5675.126
2026-02-2056.8922,60147.919
2026-02-1942.0282,60109.273
2026-02-18163.1502,66433.979
2026-02-1720.3282,5151.023
2026-02-113.4612,689.275
2026-02-10280.4002,68751.472
2026-02-0624.9662,4561.167
2026-02-0526.2392,5967.959
2026-02-0458.1802,73158.831
2026-02-035092,681.364
2026-02-021.6222,714.396
2026-01-3010.2422,8629.292
2026-01-295.8363,0017.508
2026-01-2717.7943,1856.585
2026-01-222.7973,379.426
2026-01-2058.6283,35196.404
2026-01-164123,361.384
2026-01-159933,353.327
2026-01-124504,181.881
2026-01-066.0703,9223.794
2025-12-318.6003,6531.390
2025-12-302.8943,6510.563
2025-12-2913.6423,6449.657
2025-12-2621.8283,5276.835
2025-12-2410.5743,3835.740
2025-12-233.2023,3910.855
2025-12-172043,84783

Hinweis

Erweitert ×